Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,382 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03274050Recruiting
Testing robotic surgery for children and adults needing operations
This trial studies how well and how efficiently robotic surgery works in both children and adults who need a procedure where robotic surgery is appropriate. It may help surgeons plan safer, smoother operations and improve operating-room efficiency.
Paris, ParisAges Any age - NCT03290456Recruiting
Prednisone plus rituximab to help keep ANCA vasculitis in remission
This trial studies whether extending low-dose prednisone alongside rituximab (given as infusions at set times) helps keep microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA) in remission. If you respond to initial treatment, the goal is to reduce the chance of relapse and maintain disease control.
AmiensAges 18 years+ - NCT03344016Recruiting
Study of pheochromocytoma and paraganglioma in patients
This study looks at people who have been newly diagnosed with pheochromocytoma/paraganglioma (PPGL), those with a past history of PPGL, or those with genetic risk for it. It may help doctors better evaluate and understand PPGL using specific tests.
ZurichAges 5 years+ - NCT03392337Recruiting
Narrowband UVB light therapy for moderate to severe plaque psoriasis
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
East Windsor, New JerseyAges 18 years+ - NCT03414827Recruiting
Genetic testing study for kidney cancer
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
RoskildeAges Any age - NCT03427996Recruiting
Study of rotational stent treatment in everyday care
This trial looks at how safe and effective rotational atherectomy (a procedure used to treat blocked heart arteries) is when used in routine clinical practice. It mainly gathers follow-up information from adults who already had this procedure.
Bucheon-siAges 19 years+ - NCT03443999Recruiting
Registry to follow patients with a sirolimus stent
This study is a follow-up registry that tracks how people do after doctors place a specific type of drug-eluting coronary stent. It may help doctors understand safety and outcomes of the Supraflex stent in real-world care.
Breda, North BrabantAges 18 years+ - NCT03460769Recruiting
Mixed meal test to study diabetes from pancreas conditions
This study uses a special blood-sugar test (a mixed meal) to better diagnose and understand diabetes related to pancreatic cancer or chronic pancreatitis, and to compare it with other diabetes types. It may help researchers find clearer ways to tell these diabetes causes apart and understand how they work.
Los Angeles, CaliforniaAges 30–84 - NCT03461237Recruiting
Study of care after osteoporotic hip fractures
This study looks at people with osteoporotic hip fractures (breaks in the femur near the hip) and evaluates their care and outcomes. It may help improve how hip fractures are treated in people whose bones are weaker due to osteoporosis.
Beijing, Beijing MunicipalityAges 50–95 - NCT03463668Recruiting
Testing a specific duodenal stent for duodenal narrowing
This trial is looking back at people with symptoms from narrowing of the duodenum (the first part of the small intestine) who had a specific type of stent placed between 2010 and 2017. It may help doctors understand how well these “uncovered” duodenal stents work over time, and who benefits.
Marseille, Bouches Du RhoneAges 18 years+ - NCT03463954Recruiting
Laser treatment trial for small breast tumors
This trial tests a focused laser treatment (Novilase®) to destroy small, cancerous breast tumors while aiming to work with standard care. It may help people who have an early, localized tumor that can be clearly seen on imaging so doctors can guide the laser safely.
Duarte, CaliforniaAges 18 years+ - NCT03472157Recruiting
Bariatric surgery for severe NASH with advanced liver scarring
This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.
LilleAges 18–65 - NCT03478852Recruiting
Epilepsy screening and evaluation for people 8 and older
This study checks how people with known or suspected epilepsy are evaluated and followed. It may help by improving screening and understanding care for epilepsy in children and adults.
Bethesda, MarylandAges 8–110 - NCT03481647Recruiting
Oral care program for people getting head and neck radiation
This trial tests an oral (mouth) care program for people with head and neck cancer who are about to start full-dose, curative radiation. It may help protect your mouth and salivary glands during treatment.
GothenburgAges 18–80 - NCT03502408Recruiting
CT or MRI blood-flow imaging in strokes treated within 6–24 hours
This study checks how well CT or MRI “blood-flow” scans predict and measure brain injury in people with an acute ischemic stroke who are getting a clot-removing procedure. It may help doctors choose the right people for treatment and evaluate treatment effects using imaging taken soon after hospital arrival.
Hangzhou, ZhejiangAges 18 years+ - NCT03535545RecruitingPhase 1
PET-MRI imaging test in lung cancer and lung disease
This Phase 1 study tests a radioactive imaging agent to help doctors see disease activity in the lungs using PET/MRI scans. It includes healthy volunteers and people with lung cancer, idiopathic pulmonary fibrosis, lung transplant–related lung problems, or certain medication-related lung inflammation.
Boston, MassachusettsAges 18–80 - NCT03559569Recruiting
Study blood changes in people with circulatory shock
This study looks at how blood vessel and white blood cell aging changes during circulatory shock. Your participation may help doctors better understand what’s happening in the body during shock.
StrasbourgAges 18 years+ - NCT03577041Recruiting
Cost study of eye injections for new macular degeneration
This study evaluates the cost-effectiveness of three anti-VEGF eye injection treatments (bevacizumab, ranibizumab, or aflibercept) for patients with newly diagnosed age-related macular degeneration affecting the center of vision. The research aims to understand which treatment option provides the best medical and financial value in France.
AmiensAges 18–70 - NCT03579836RecruitingPhase 1/Phase 2
Test BEY1107 plus gemcitabine for pancreatic cancer
This early study tests whether BEY1107 given alone or with gemcitabine can be used safely and may help shrink pancreatic cancer tumors. It mainly looks at safety, side effects, and signs of effectiveness in people with pancreatic ductal cancer.
SeoulAges 20–80 - NCT03607565Recruiting
Imaging test to measure brain blood flow in stroke
This trial studies a new imaging measurement derived from DSA (a special type of brain blood-vessel scan) to better estimate how well blood is flowing in the brain. It may help doctors assess stroke-related blood-flow problems, but it excludes people who have brain bleeding.
Xi'an, ShaanxiAges Any age - NCT03617237Recruiting
Radiation patient registry for cancer and non-cancer cases
This study keeps records to understand outcomes for people who had radiation treatment (or were evaluated for it) since 2000. It may help doctors compare results for different conditions and treatment approaches, including cancer and non-cancer problems.
Dallas, TexasAges 18–99 - NCT03619850RecruitingPhase 3
Ferumoxytol vs iron sucrose for child kidney anemia
This study compares two IV iron treatments—ferumoxytol and iron sucrose—to treat iron deficiency anemia in children with chronic kidney disease. It aims to see which option works better and is safe, and also to learn how each medicine behaves in the body.
Hollywood, FloridaAges 2–17 - NCT03624244RecruitingPhase 2
Stopping or continuing hormone pill for low-grade uterine cancer
This Phase 2 trial tests whether it is better to stop a hormone tablet (an aromatase inhibitor) versus keep taking it in people with low-grade endometrial stromal sarcoma whose cancer is currently controlled. It may help find the safest way to maintain disease control while avoiding unnecessary treatment if stopping is possible.
BesançonAges 18 years+ - NCT03671044RecruitingPhase 3
Testing a nano-form of docetaxel for triple-negative breast cancer
This Phase 3 study tests whether a special form of docetaxel (a chemotherapy drug) works better and is safe for people with triple-negative breast cancer that has spread or grown locally. You may be eligible if your cancer is triple-negative and you have measurable disease that can be tracked on scans, along with adequate organ and heart function.
Columbus, GeorgiaAges 18–65
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,382 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.